Peptide Decoding
New?New to peptides?Start here →
Decoding

Zovaglutide (ZT-002)_Dosage, benefits & legal status

Also known as ZT-002, Zovaglutide

Published July 22, 2026 · Updated August 14, 2026

An experimental once-a-month weight-loss shot.

Weight lossGLP-1 agonistInvestigational
Dose80 up to 160 mg per month (trial doses)
FrequencyMonthly
RouteUnder the skin (subcutaneous)
StatusInvestigational
CycledNot cycled in the trials

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Zovaglutide (ZT-002)?

Plain language first. The technical label stays, but it never stands alone.

Overview

It gives the usual GLP-1 appetite control but lasts long enough to inject just once a month. It is still experimental.

The technical version

Zovaglutide is a long-acting GLP-1 receptor agonist.

What it's used for

An experimental once-a-month weight-loss shot, with about 14% loss in early testing.

02

How does Zovaglutide (ZT-002) work?

What it does in the body, and where.

Zovaglutide is a GLP-1 agonist engineered to last long enough for monthly dosing.

  1. 01
    Standard GLP-1 receptor activation
    Nothing unusual about the mechanism itself.
  2. 02
    The difference is how long it circulates
    Long enough to inject once every four weeks rather than weekly, which is a meaningful difference in adherence over years.
  3. 03
    Investigational, and data so far is from conference presentations
    Phase 2 results were presented at EASD in 2025. Treat as provisional until published.
Anatomical illustration highlighting metabolic organs
WHAT THIS COMPOUND ACTS ON:
GLP-1Fullness, slower stomach
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Weight loss with once-a-month dosingInvestigational

The published record

Research index

10

Papers and trials about Zovaglutide (ZT-002)

Searched: Zovaglutide, ZT-002.

10 papers tagged human · 0 not reviews or lab · 0 clinical trial publications

10 registered trials · none with posted results

Furthest stage reached: Phase 3, under way

Compare this against the whole library →

In animals0
In the lab0
Reviews0
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Zovaglutide (ZT-002) vial rendering
Compound field notes

At a glance

Four things to know about Zovaglutide (ZT-002)

01

Evidence

Investigational

02

Category

Weight loss and metabolic

03

Common vial

Varies

04

Half-life

About 11 days

04

How much, and do you cycle it?

The range, and whether you take breaks.

80 up to 160 mg per month (trial doses), monthly. Not cycled in the trials Trial dose

Given continuously for the whole study period: HORIZON-1, 52 weeks. The dose is stepped up at the start, which is a ramp rather than a cycle, and no trial in this class built in a planned break.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 11 daysTrial protocol

Dosed once a month.

Source: First-in-human single ascending dose study, ADA 2024 abstract 119-OR

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Enter the amount printed on your label.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 80 up to 160 mgTrial dose

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
07

How do you store it?

Before mixing, and after.

Nothing to store: it is not sold anywhere.

Zovaglutide (ZT-002) has never been marketed, so there is no vial, pen or bottle to keep at home. Supplies for a trial are made, stored and dispensed by the sponsor and the trial pharmacy under conditions set in the protocol. Anything offered for sale under this name did not come from that supply chain.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

This compound is in clinical trials and is not sold in a standard vial, so there is no common vial size to show. Trial doses are given as prepared by the study, and the reconstitution calculator does not apply. Doses up to 160 mg a month are sixteen times the 10 mg reference vial.

Who should avoid it

Check these before anything else.
  • No formal contraindications established
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Vomiting badly enough that you cannot keep fluids down
  • Severe stomach pain that spreads to your back
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Stomach effects typical of this drug family
  • Detailed figures have not been published in a peer-reviewed journal, only presented at a conference

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Zovaglutide (ZT-002) approved?

And where the numbers on this page come from.

No. Zovaglutide (ZT-002) is not approved anywhere and is currently in company-run clinical trials. There is no legal route to obtain it outside a trial.

  • Approval status
    Investigational
  • Route
    Under the skin (subcutaneous)
  • Checked
    14 August 2026
  • Dose
    From published clinical trials. Not approved by a regulator for this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 10 records are indexed. Browse the records